Promouvoir l'accès aux technologies médicales et l'innovation: Intersections entre la santé publique, la propriété intellectuelle et le commerce (deuxième édition)

La coopération internationale en matière de santé publique est par essence multidimensionnelle, l'accent étant mis sur la mise en place de systèmes de santé efficace. Dans cet objectif, l'Organisation mondiale de la santé (OMS), l'Organisation mondiale de la propriété intellectuelle (OMPI) et l'Organisation mondiale du commerce (OMC) œuvrent ensemble étroitement, conjointement avec d'autres partenaires internationaux, depuis presque deux décennies pour soutenir les initiatives mondiales visant à améliorer la situation sanitaire. Dans le cadre de leurs efforts pour aider les pays à développer leur capacité à faire faire aux défis multidimensionnels qui se posent dans le secteur de la santé publique, les trois organisations ont lancé la deuxième édition de l'étude trilatérale intitulée "Promouvoir l'accès aux technologies médicales et l'innovation".

Access to essential medicines and the lack of research to address neglected diseases have been a major concern for many years. To promote innovation and to ensure equitable access to all vital medical technologies, such as medicines, vaccines and medical devices, policy-makers need a clear understanding of the innovation processes that lead to new technologies and the ways in which these technologies are disseminated. This publication seeks to improve understanding of the interplay between the distinct policy domains of health, trade and intellectual property, and how they affect medical innovation and access to medical technologies.

This second edition captures new developments in key areas since the launch of the first study in 2013. Among the new topics covered in this edition are antimicrobial resistance and cutting-edge health technologies. The publication provides updated data on health, innovation trends in the pharmaceutical sector, and trade and tariffs relating to medical products. It includes an updated overview of access to medical technologies globally and key provisions in regional trade agreements. It also takes account of developments in intellectual property legislation and jurisprudence.

Since this study was completed prior to the COVID-19 outbreak, a standalone section on COVID-19 was added at the start of the publication to map the multiple challenges posed by the pandemic in relation to the integrated health, trade and IP policy frameworks set out in the study. It guides the reader to the parts of the main text that are particularly relevant to the issues raised during the pandemic.

The publication is the result of a collaborative effort by the WHO, WIPO and the WTO, drawing together the three secretariats' respective areas of expertise. It is intended to inform ongoing technical cooperation activities undertaken by the three organizations and to support policy discussions.

Drawing on longstanding experiences in joint technical cooperation activities, the publication has been prepared to serve the needs of policy-makers as well as lawmakers, government officials, delegates to international organizations, non-governmental organizations and researchers.

For the time being, the second edition is available in English only. The first edition of the study is also available in French and Spanish.

Co-published by the World Health Organization, the World Intellectual Property Organization and the World Trade Organization in July 2020.

Download by section

imagen de la publicación

Télécharger au format pdf


Commander la publication




Des problèmes pour visualiser cette page?
Veuillez écrire à en indiquant le système d’exploitation et le navigateur que vous utilisez.